Table 1 Baseline characteristics of the study population.
Variable | Value |
|---|---|
Patient characteristics | |
Age (year) | |
Mean ± SD (range) | 68.9 ± 9.6 (37–85) |
Gender | |
Male | 124 (82.1) |
Female | 27 (17.9) |
Underlying liver disease | |
Hepatitis C virus | 61 (40.4) |
Hepatitis B virus | 26 (17.2) |
Hepatitis B and C virus | 3 (2.0) |
Nonalcoholic steatohepatitis | 43 (28.5) |
Alcoholic | 14 (9.3) |
Others | 4 (2.6) |
Child–Pugh classification | |
A | 149 (98.7) |
B | 2 (1.3) |
C | 0 (0) |
AFP (ng/mL) | |
Median (interquartile range) | 11 (5–53) |
< 20 ng/mL | 92 (60.9) |
≥ 20 ng/mL | 59 (39.1) |
Histopathological findings | |
Tumor size of HCC (mm) | |
Median (interquartile range) | 38 (24–62) |
< 10 mm | 4 (2.7) |
10–20 mm | 28 (18.5) |
≥ 20 mm | 119 (78.8) |
Fibrous capsule in HCC | |
Presence | 124 (82.1) |
Absence | 27 (17.9) |
Histological differentiation of HCC | |
Well-differentiated | 14 (9.3) |
Moderately-differentiated | 115 (76.2) |
Poorly-differentiated | 22 (14.5) |
METAVIR fibrous score | |
F0 | 15 (9.9) |
F1 | 26 (17.2) |
F2 | 47 (31.1) |
F3 | 39 (25.9) |
F4 | 24 (15.9) |
